# Payal Kapur

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/payal-kapur/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,061 |
| Field | Renal cell carcinoma treatment |
| h-index | 60 |
| i10-index | 189 |
| Last Known Institution | Southwestern Medical Center |
| OpenAlex ID | https://openalex.org/A5069595062 |
| ORCID iD | https://orcid.org/0000-0002-4239-0495 |
| Works | 561 |

## Researcher papers

- [BAP1 loss defines a new class of renal cell carcinoma](https://scholariq.org/papers/bap1-loss-defines-a-new-class-of-renal-cell-carcinoma/)
- [Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/kidney-cancer-version-3-2022-nccn-clinical-practice-guidelines-in-oncology/)
- [A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma](https://scholariq.org/papers/a-validated-tumorgraft-model-reveals-activity-of-dovitinib-against-renal-cell/)
- [NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024](https://scholariq.org/papers/nccn-guidelines-insights-kidney-cancer-version-2-2024/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.